SEC Form 4 · accession 0001209191-17-020904
OPKO HEALTH, INC. · OPK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Logal
Officer — Sr. Vice President, CFO
Period of report
Mar 13, 2017
Accepted (ET)
Mar 15, 2017 · 6:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000944809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 13, 2017 | M | 189,207 | $0.56 | A | 234,996 | D | |
| Common Stock | Mar 13, 2017 | M | 75,000 | $2.36 | A | 309,996 | D | |
| Common StockF1,F2 | Mar 13, 2017 | F | 35,728 | $7.92 | D | 274,268 | D | |
| Common StockF3,F4 | Mar 14, 2017 | S | 112,975 | $8.0697 | D | 161,293 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $0.56 | Mar 13, 2017 | M | 189,207 | D | — | Mar 15, 2017 | Common Stock | 189,207 | 0 | D |
| Stock Option (Right to Buy)F6 | $2.36 | Mar 13, 2017 | M | 75,000 | D | — | Apr 13, 2017 | Common Stock | 75,000 | 0 | D |
Explanation of responses
- F1Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price. No shares of Common Stock were sold by the reporting person in connection with this transaction. The reporting person has retained the net number of shares issued upon the exercise of the option (228,479 shares).
- F2Closing market price of the Company's common stock on the transaction date.
- F3All of the shares reported as disposed of in this Form 4 were sold to pay/satisfy federal and/or state tax withholding in connection with a stock option exercise on March 13, 2017. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.21, inclusive. The reporting person undertakes to provide to OPKO Health, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
- F5This option became exercisable in forty-eight (48) equal monthly installments until fully vested on March 15, 2011.
- F6The options were granted on April 14, 2010 and vested in four equal installments beginning on April 14, 2011.